Could many heart patients ditch Beta-Blockers? new trial investigates
NCT ID NCT05081999
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether people with stable ischemic heart disease (but with normal heart pumping function and no ongoing chest pain or arrhythmias) can safely stop taking beta-blockers. About 59 participants will either continue or stop their beta-blocker and be followed for up to 4 years to compare heart events and quality of life. The goal is to see if stopping the drug reduces side effects without increasing risk.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
beta-blocker discontinuation
What this could lead to
If successful, this could show that many stable heart disease patients can safely stop taking beta-blockers, reducing side effects and medication burden.
What could go wrong
This is a small, early-phase pragmatic trial with only 59 participants, so results may not apply broadly. There is a risk that stopping beta-blockers could increase heart events.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Alberta Hospital
Edmonton, Alberta, T6G 2B7, Canada